SCHEMBL8470830

SCHEMBL8470830

CN1CCc2ccc(NC(=O)[C@H]3CC(O)CN3C(=O)Nc3ccc(Cl)cc3)cc2CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 4/20 0.57
POLB P06746 2/20 0.53
KLKB1 P03952 4/20 0.47
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
DRD2 P14416 1/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
CYP2C19 P33261 1/20 0.43
DRD3 P35462 1/20 0.43
HTR6 P50406 1/20 0.43
MAPT P10636 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
KCNA1 Q09470 1/20 0.42
KCNAB1 Q14722 1/20 0.42
GAA P10253 1/20 0.42
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12371425 1.00 F10 (0.57) F10POLBKLKB1CYP1A2CYP3A4
SCHEMBL12371426 0.90 MEN1 (0.53) F10POLBKLKB1MAPTMEN1
SCHEMBL12371471 0.90 F10 (0.46) F10POLBCYP1A2CYP3A4CYP2D6
SCHEMBL8471194 0.90 MEN1 (0.53) F10POLBKLKB1MAPTMEN1
SCHEMBL12101338 0.87 MEN1 (0.50) F10POLBKLKB1MAPTMEN1
SCHEMBL8471226 0.87 F10 (0.54) F10POLBKLKB1CYP1A2CYP3A4
SCHEMBL12371472 0.86 F10 (0.43) F10POLBKLKB1CYP1A2CYP3A4
SCHEMBL13104152 0.85 F10 (0.52) F10POLBKLKB1CYP1A2CYP3A4
SCHEMBL12101291 0.85 F10 (0.52) F10POLBKLKB1CYP1A2CYP3A4
SCHEMBL12101293 0.84 F10 (0.53) F10POLBKLKB1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1818330-A1 Substituted proline amides, preparation and use as medicaments thereof Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2007-08-15 EP disclosed